Valion Bio, Inc. (VBIO)

CIK 1787740 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Valion Bio, Inc..

Recent SEC filings

FiledFormAccession number
Oct 8, 2026S-30001683168-26-007707
Oct 8, 20268-K0001683168-26-007709
Oct 6, 20268-K0001437749-26-032107
Oct 2, 2026PRE 14A0001683168-26-007588
Oct 1, 20268-K0001683168-26-007514
Sep 24, 202640001683168-26-007398
Sep 24, 202640001683168-26-007396
Sep 23, 20268-K0001683168-26-007300
Sep 17, 202630001683168-26-007217
Sep 17, 202630001683168-26-007216
Sep 4, 2026SCHEDULE 13G/A0001753926-26-001726
Sep 3, 2026SCHEDULE 13D/A0001753926-26-001719
Sep 2, 2026SCHEDULE 13D/A0001753926-26-001702
Sep 1, 20268-K0001683168-26-006848
Aug 27, 20268-K0001683168-26-006742
Aug 27, 2026SCHEDULE 13D/A0001753926-26-001647
Aug 24, 2026RW0001683168-26-006676
Aug 24, 2026SCHEDULE 13D/A0001753926-26-001610
Aug 20, 20268-K/A0001683168-26-006632
Aug 19, 2026SCHEDULE 13D/A0001753926-26-001562
Aug 17, 20268-K0001683168-26-006501
Aug 14, 2026SCHEDULE 13D/A0001753926-26-001528
Aug 14, 202610-Q0001437749-26-028069
Aug 12, 2026EFFECT9999999995-26-002641
Aug 11, 2026SCHEDULE 13D/A0001753926-26-001421